论文部分内容阅读
目的观察盐酸消旋山茛菪碱注射液(654-2)辅助治疗眩晕症的临床疗效。方法 124例眩晕症患者随机分成对照组与观察组,各62例。对照组采用甘露醇、复方丹参注射液、胞二磷胆碱针联合治疗,观察组在此基础上加用654-2治疗,对比两组的疗效、不良反应、头晕缓解时间及医疗费情况。结果观察组治疗总有效率、头晕缓解时间明显优于对照组(P<0.05);两组不良反应发生率、医疗费差异无统计学意义(P>0.05)。结论 654-2辅助治疗眩晕症可有效提高疗效及促进患者临床症状的缓解,且不增加不良反应及医疗费,是较为理想的治疗方式。
Objective To observe the clinical efficacy of analgesic hydrochloride anisodamine injection (654-2) in the treatment of vertigo. Methods 124 cases of vertigo patients were randomly divided into control group and observation group, 62 cases each. The control group was treated with mannitol, compound Danshen injection and citicoline, and the observation group was treated with 654-2. The curative effect, adverse reaction, dizziness relief time and medical expenses of the two groups were compared. Results The total effective rate and dizziness relieving time in the observation group were significantly better than those in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions and medical expenses between the two groups (P> 0.05). Conclusion 654-2 adjuvant treatment of vertigo can effectively improve the efficacy and promote the alleviation of clinical symptoms, without increasing adverse reactions and medical costs, is an ideal treatment.